BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 12107916)

  • 1. [Physiopathology of refractory ascites and the hepatorenal syndrome].
    Arroyo V
    Nefrologia; 2002; 22 Suppl 5():41-6. PubMed ID: 12107916
    [No Abstract]   [Full Text] [Related]  

  • 2. Ascites and hepatorenal syndrome: pathogenesis and treatment strategies.
    Ginès P; Arroyo V; Rodés J
    Adv Intern Med; 1998; 43():99-142. PubMed ID: 9506180
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of ascites and hepatorenal syndrome.
    Piano S; Tonon M; Angeli P
    Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatorenal syndrome.
    Biswas KD; Jain AK
    Trop Gastroenterol; 2002; 23(3):113-6. PubMed ID: 12693150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascites and Hepatorenal Syndrome.
    Adebayo D; Neong SF; Wong F
    Clin Liver Dis; 2019 Nov; 23(4):659-682. PubMed ID: 31563217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion.
    Guevara M; Ginès P; Fernández-Esparrach G; Sort P; Salmerón JM; Jiménez W; Arroyo V; Rodés J
    Hepatology; 1998 Jan; 27(1):35-41. PubMed ID: 9425914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.
    Gentilini P; Laffi G; La Villa G; Raggi VC
    Ann Ital Med Int; 1999; 14(4):264-84. PubMed ID: 10638019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention?
    Møller S; Henriksen JH
    Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():31-41; discussion 42-3. PubMed ID: 15335398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluid retention in cirrhosis: pathophysiology and management.
    Kashani A; Landaverde C; Medici V; Rossaro L
    QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of hepatorenal syndrome].
    Guevara M
    Gastroenterol Hepatol; 2003 Apr; 26(4):270-4. PubMed ID: 12681123
    [No Abstract]   [Full Text] [Related]  

  • 11. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.
    Arroyo V; Ginès P; Gerbes AL; Dudley FJ; Gentilini P; Laffi G; Reynolds TB; Ring-Larsen H; Schölmerich J
    Hepatology; 1996 Jan; 23(1):164-76. PubMed ID: 8550036
    [No Abstract]   [Full Text] [Related]  

  • 12. Is there still a need for albumin infusions to treat patients with liver disease?
    Ginès P; Arroyo V
    Gut; 2000 May; 46(5):588-90. PubMed ID: 10764695
    [No Abstract]   [Full Text] [Related]  

  • 13. Ascites.
    Gordon FD
    Clin Liver Dis; 2012 May; 16(2):285-99. PubMed ID: 22541699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatorenal syndrome.
    Gattoni A; Marotta F; Vangieri B; Pisani G; Cristiano F
    Clin Ter; 2004 Sep; 155(9):375-89. PubMed ID: 15700631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portal hypertension.
    Garcia-Tsao G
    Curr Opin Gastroenterol; 2006 May; 22(3):254-62. PubMed ID: 16550040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.
    Salerno F; Guevara M; Bernardi M; Moreau R; Wong F; Angeli P; Garcia-Tsao G; Lee SS
    Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of ascites in cirrhosis and portal hypertension.
    Heneghan MA; Harrison PM
    Med Sci Monit; 2000; 6(4):807-16. PubMed ID: 11208415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ascites--a sign of death?].
    Nordin A; Mäkisalo H
    Duodecim; 2000; 116(19):2074-83; quiz 2084, 2165. PubMed ID: 12017728
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vasoconstrictors in the treatment of hepatorenal syndrome].
    Ortega R; Calahorra B; Ginès P
    Nefrologia; 2002; 22 Suppl 5():56-61. PubMed ID: 12107919
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of ascites in the patient with portal hypertension with emphasis on spontaneous bacterial peritonitis.
    Navasa M; Rodés J
    Semin Gastrointest Dis; 1997 Oct; 8(4):200-9. PubMed ID: 9360284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.